Kerz Thomas, Boor Stephan, Beyer Christian, Welschehold Stefan, Schuessler Anke, Oertel Joachim
Department of Neurosurgery, University Medical Center, Johannes Gutenberg University, Mainz, Germany.
Br J Neurosurg. 2012 Aug;26(4):517-24. doi: 10.3109/02688697.2011.650737. Epub 2012 Feb 3.
Papaverine (P) and nimodipine (N) are the most widely used vasodilators when angiographic and symptomatic vasospasm is present after subarachnoid aneurysmatic hemorrhage (SAH). Their effect is only short-lived and no direct comparisons have been undertaken to evaluate the action of both substances directly. We retrospectively assessed the effect of either P or N on angiographic diameter reduction and capillary blood flow.
Fifteen SAH patients with secured aneurysms and cerebral vasospasm received intraarterial P, fifteen similar patients received N. As the primary endpoint, pre- and post-infusion arterial diameters and capillary blood flow were rated retrospectively on angiographies and compared by RM-ANOVA. Secondary endpoints were the difference in the modified Rankin Scale between the two groups on admission and at discharge, the occurrence of delayed cerebral ischemia, the separate effects on angiographic diameter and capillary blood flow and the overall response rate to the vasodilator infusion.
Angiographic resolution of diameter reduction and angiographically assessed capillary blood flow together differed not significantly between both groups. P infusion dilated all angiographic demonstrable vessels while N infusion was ineffective in 16% of the patients. Capillary flow on pre- and post-infusion angiographies was not different between the two groups.
P and N seem to differ in the effect on cerebral diameter reduction in patients with vasospasm after SAH. The clinical implications remain to be established. A multimodal approach, perhaps combining different agents for intraarterial infusion in such patients, needs to be evaluated.
罂粟碱(P)和尼莫地平(N)是蛛网膜下腔动脉瘤性出血(SAH)后出现血管造影和症状性血管痉挛时最常用的血管扩张剂。它们的作用只是短暂的,尚未进行直接比较以评估这两种物质的直接作用。我们回顾性评估了P或N对血管造影直径缩小和毛细血管血流的影响。
15例患有已栓塞动脉瘤和脑血管痉挛的SAH患者接受动脉内P治疗,15例类似患者接受N治疗。作为主要终点,回顾性评估血管造影上输注前后的动脉直径和毛细血管血流,并通过重复测量方差分析进行比较。次要终点是两组入院时和出院时改良Rankin量表的差异、迟发性脑缺血的发生、对血管造影直径和毛细血管血流的单独影响以及血管扩张剂输注的总体反应率。
两组在血管造影直径缩小的分辨率和血管造影评估的毛细血管血流方面总体差异不显著。P输注使所有血管造影可显示的血管扩张,而N输注在16%的患者中无效。两组输注前后血管造影上的毛细血管血流无差异。
P和N对SAH后血管痉挛患者脑直径缩小的影响似乎不同。其临床意义仍有待确定。可能需要评估一种多模式方法,或许将不同药物联合用于此类患者的动脉内输注。